MVB Financial Corp's Chief Risk and Compliance Officer, Julie Allison Oconnor, filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 2,500 restricted stock units on November 5, 2026.
Prabha S. Bhandari, Chief Legal Officer and Secretary of Houlihan Lokey, Inc. (NYSE:HLI), filed a Form 4 on November 9, 2026, disclosing three equity grants of Class B Common Stock made on November 5, 2026, totaling 12,980 shares, plus a concurrent disposition of 12,980 …
Fund 1 Investments, LLC filed a Form 4 with the SEC on November 9, 2026, reporting the sale of 750,000 shares of Citi Trends Inc common stock on November 5, 2026.
MVB Financial Corp. filed a current report on November 9, 2026, disclosing that on November 5, 2026, it entered into Restated Executive Employment Agreements with four senior officers, amending and superseding their prior employment agreements.
Ricardo Roizen Gottlieb, Interim Chief Financial Officer of Fluence Energy, Inc., filed an initial statement of beneficial ownership on November 9, 2026, with an event date of October 30, 2026.
Julie Allison Oconnor, Chief Risk and Compliance Officer at MVB Financial Corp, filed an initial statement of beneficial ownership (Form 3) on November 9, 2026, with a triggering event date of November 5, 2026.
Franklin S. Edmonds Jr. filed an initial statement of beneficial ownership with the SEC on November 9, 2026, reporting his status as a newly appointed director of KLX Energy Services Holdings, Inc. as of October 29, 2026.
Director Grant C. Bogle of Immuneering Corp filed a Form 4 on November 9, 2026, disclosing the acquisition of stock options covering 66,700 shares of Class A Common Stock at an exercise price of $3.65 per share.
Immuneering Corporation filed a Form 8-K on November 9, 2026, disclosing the appointment of Grant C. Bogle, MBA, to its Board of Directors as a Class III Director, effective the same date.
Director Grant C. Bogle filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing no securities held in Immuneering Corp (NASDAQ:IMRX).